(Reuters) - The company said it disagrees with the decision by the United States Patent and Trademark Office not to extend the patent beyond 2010 and will seek a review.
Angiomax, a synthetic form of an anticlotting compound found in the saliva of leeches, is used to prevent blood clots in patients undergoing coronary angioplasty procedures.
Read more at Reuters.com Government Filings News
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment